TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension

Ocular Inflammation Associated With Blepharaconjunctivitis Clinical Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to describe the differences in efficacy between TOBRADEX Ophthalmic Suspension and Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension in the treatment of ocular inflammation and infection associated with blepharaconjunctivitis

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Inflammation
• Ocular Inflammation Associated With Blepharaconjunctivitis

• NCT number: NCT00576251
• Study type: Interventional
• Source: Alcon Research
• Status: Completed
• Phase: Phase 3
• Start date: October 2007
• Completion date: March 2008